SignatureFD’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-422
Closed -$1.48K 3319
2024
Q3
$1.48K Sell
422
-53
-11% -$186 ﹤0.01% 2901
2024
Q2
$1.56K Sell
475
-388
-45% -$1.27K ﹤0.01% 2812
2024
Q1
$6.33K Buy
863
+503
+140% +$3.69K ﹤0.01% 2468
2023
Q4
$1.35K Sell
360
-624
-63% -$2.34K ﹤0.01% 2849
2023
Q3
$2.09K Sell
984
-3,070
-76% -$6.52K ﹤0.01% 2754
2023
Q2
$19.3K Buy
4,054
+855
+27% +$4.07K ﹤0.01% 1910
2023
Q1
$18.2K Buy
3,199
+918
+40% +$5.23K ﹤0.01% 1919
2022
Q4
$23K Buy
2,281
+1,130
+98% +$11.4K ﹤0.01% 1733
2022
Q3
$26K Buy
1,151
+81
+8% +$1.83K ﹤0.01% 1608
2022
Q2
$27K Buy
1,070
+199
+23% +$5.02K ﹤0.01% 1618
2022
Q1
$34K Buy
871
+283
+48% +$11K ﹤0.01% 1553
2021
Q4
$34K Sell
588
-313
-35% -$18.1K ﹤0.01% 1522
2021
Q3
$53K Sell
901
-6
-0.7% -$353 ﹤0.01% 1269
2021
Q2
$79K Buy
907
+715
+372% +$62.3K ﹤0.01% 1060
2021
Q1
$16K Hold
192
﹤0.01% 1644
2020
Q4
$17K Sell
192
-11
-5% -$974 ﹤0.01% 1508
2020
Q3
$8K Buy
203
+48
+31% +$1.89K ﹤0.01% 1707
2020
Q2
$5K Hold
155
﹤0.01% 1788
2020
Q1
$3K Buy
+155
New +$3K ﹤0.01% 1809